2015

García-Sánchez O, Sancho-Martínez SM, López-Novoa JM, López-Hernández FJ. Activation of the ALK-5 pathway is not per se sufficient for the antiproliferative effect of TGF-β on renal tubule epithelial cells. Cell Physiol Biochem. 2015; 37:1231-1239.

Sancho-Martínez SM, López-Novoa JM, López-Hernández FJ. Pathophysiological role of different tubular epithelial cell death modes in acute kidney injury. Clinical Kidney Journal. 2015; 8:548-59.

Sancho-Martínez SM, Prieto-García L, Blanco-Gozalo V, Fontecha M, López-Novoa JM, López-Hernández FJ. Urinary proteomics in renal pathophysiology: Impact of proteinuria. Proteomics Clin Appl. 2015; 9: 636-40.

Blázquez-Medela M, García-Sánchez O, Quirós Y, Blanco-Gozalo V, Prieto-García L, Sancho-Martínez SM, Romero M, Duarte JM, López-Hernández FJ, López-Novoa JM, Martínez-Salgado C. Increased KLK9 urinary excretion is associated to hypertension-induced cardiovascular damage and renal alterations. Medicine 94 (41): e1617, 2015.

Muñoz-Félix M, González-Núñez M, Martínez-Salgado C, López-Novoa JM. TGF-β and BMPs inhibitors in renal fibrosis. Where have we arrived after 25 years of trials and troubles? Pharmacology & Therapeutics 156: 44-58, 2015.

Sancho-Martínez SM, Prieto L, Blanco-Gozalo V, Fontecha-Barriuso M, Vicente-Vicente L, Casanova AG, Prieto M, Pescador M, Morales AI, López-Novoa JM, Martínez-Salgado C, López-Hernández FJ. Acute tubular necrosis: An old termin search for a new meaning within the evolving concept of acute kidney injury. New Horizons in Translational Medicine 2: 110–117, 2015

Gamella-Pozuelo L, Fuentes-Calvo I, M. Gómez-Marcos MA, Recio-Rodriguez JI, Agudo-Conde C, Fernández-Martín JL, Cannata-Andía JB, López-Novoa JM, García-Ortiz L, Martínez-Salgado C. Plasma cardiotrophin-1 as a marker of hypertension and diabetes-induced target organ damage and cardiovascular risk. Medicine 94(30): e1218, 2015.

Sancho-Martínez SM, Prieto-García L, Blanco-Gozalo V, Fontecha-Barriuso M, López-Novoa JM, López-Hernández FJ. Urinary proteomics in renal pathophysiology: Impact of proteinuria. Proteomics Clin Appl 9: 636-640, 2015

Vicente-Vicente L, Sánchez-Juanes F, García-Sánchez O, Blanco-Gozalo V, Pescador M, Sevilla MA, González-Buitrago JM, López-Hernández FJ, López-Novoa JM, Morales AI. Sub-nephrotoxic cisplatin sensitizes rats to acute renal failure and increases urinary excretion of fumarylacetoacetase. Toxicol Lett. 234: 99-109, 2015.